Just - Evotec Biologics
Linda Zuckerman, Ph.D. is currently the EVP of Just-Evotec Biologics, Global Head of Biotherapeutics, and Senior Vice President of Business Development at the same company. Previously, Linda served as President & CEO at Xcede Technologies, Inc., where she led the development of hemostatic and sealant products for surgical applications. She also held the position of President and CEO at ID Genomics SPC, focusing on combating antibiotic resistance. With a background in immunology and biochemistry, Linda has held various leadership roles in companies such as The Medicines Company, ProFibrix, ZymoGenetics, and Genentech.
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com